Skip To Main Content
Carrie Maynard on Muck Rack

Carrie Maynard

As seen in: Drug Target Review

Get in touch with Carrie

Contact Carrie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Carrie Maynard’s Journalist Portfolio

JWHSTYLE.COM

JWHSTYLE.COM

View article →

Articles

From R&D to QC: building a single analytical strategy for cell and gene therapies

|
By Carrie Maynard, Veronica Fowler
| Drug Target Review Verified
Maintaining analytical continuity from early research through to quality control remains a challenge for many cell and gene therapy developers. At ASGCT 2026, Oxford Nanopore Technologies outlined how sequencing-based workflows could help bring multiple analytical assessments together within a single workflow. Cell and gene therapy developers face a difficult analytical challenge.
Open in Who Shared Issue with article?
See all 1 articles